Matteo Bovolenta

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Duchenne Muscular Dystrophy

Mesenchymal Stem Cells

Top Venues

Scientific reports

International journal of molecular sciences

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Juliette Lemoine, Auriane Dubois, Alan Dorval, Abbass Jaber, Ganesh Warthi, Kamel Mamchaoui, Tao Wang, Guillaume Corre, Matteo Bovolenta, Isabelle Richard
Correction of exon 2, exon 2-9 and exons 8-9 duplications in DMD patient myogenic cells by a single CRISPR/Cas9 system. Scientific reports 14 (1) (2024)
Marika Faiella, Giada Botti, Alessandro Dalpiaz, Lorenzo Gnudi, Aurelie T Goyenvalle, Barbara Pavan, Daniela Perrone, Matteo Bovolenta, Elena Marchesi
In Vitro Studies to Evaluate the Intestinal Permeation of an Ursodeoxycholic Acid-Conjugated Oligonucleotide for Duchenne Muscular Dystrophy Treatment. Pharmaceutics 16 (8) (2024)
Marika Faiella, Giada Botti, Alessandro Dalpiaz, Lorenzo Gnudi, Aurelie T Goyenvalle, Barbara Pavan, Daniela Perrone, Matteo Bovolenta, Elena Marchesi
In Vitro Studies to Evaluate the Intestinal Permeation of an Ursodeoxycholic Acid-Conjugated Oligonucleotide for Duchenne Muscular Dystrophy Treatment. Pharmaceutics 16 (8) (2024)
Elena Marchesi, Rita Cortesi, Lorenzo Preti, Paola Rimessi, Maddalena Sguizzato, Matteo Bovolenta, Daniela Perrone
Antisense Oligonucleotides Conjugated with Lipophilic Compounds: Synthesis and In Vitro Evaluation of Exon Skipping in Duchenne Muscular Dystrophy. International journal of molecular sciences 23 (8) (2022)
Elena Marchesi, Matteo Bovolenta, Lorenzo Preti, Massimo L Capobianco, Kamel Mamchaoui, Monica Bertoldo, Daniela Perrone
Synthesis and Exon-Skipping Properties of a 3'-Ursodeoxycholic Acid-Conjugated Oligonucleotide Targeting DMD Pre-mRNA: Pre-Synthetic versus Post-Synthetic Approach. Molecules (Basel, Switzerland) 26 (24) (2021)